SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer

The incidence rate of breast cancer is the highest in the world, and major problem in the clinical treatment is the therapy resistance of breast cancer stem cells (CSCs). Thus, new therapeutic approaches targeting breast CSCs are needed. Our previous study demonstrated cancer-derived sialylated IgG...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Man, Zheng, Jinhua, Guo, Junying, Zhang, Qiujin, Du, Juan, Zhao, Xiangfeng, Wang, Zhihua, Liao, Qinyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208471/
https://www.ncbi.nlm.nih.gov/pubmed/35473571
http://dx.doi.org/10.1080/21655979.2022.2063593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208471/
https://www.ncbi.nlm.nih.gov/pubmed/35473571
http://dx.doi.org/10.1080/21655979.2022.2063593

Ejemplares similares